Finally, we found that increased UBE2T level promotes GC progression via the ubiquitination of RACK1 independent of E3 ligase and identify a potent inhibitor providing a balance between growth inhibition and cytotoxicity as well, which offer a new opportunity for specific GC patients with aberrant Wnt/β-catenin signaling. Here, UBE2T is linked to gastric cancer.